Jillian Frances Wise, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immune Evasion | 1 | 2020 | 366 | 0.600 |
Why?
|
| Fas Ligand Protein | 2 | 2014 | 228 | 0.480 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1293 | 0.400 |
Why?
|
| Lymphoma, B-Cell | 2 | 2014 | 931 | 0.370 |
Why?
|
| Genome, Human | 1 | 2019 | 4471 | 0.290 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1888 | 0.250 |
Why?
|
| Phosphoproteins | 1 | 2013 | 2538 | 0.240 |
Why?
|
| Apoptosis | 5 | 2014 | 9971 | 0.240 |
Why?
|
| Cell Membrane | 1 | 2013 | 3881 | 0.230 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 313 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 2985 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4902 | 0.180 |
Why?
|
| Cytidine Deaminase | 1 | 2021 | 237 | 0.180 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2022 | 354 | 0.160 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 889 | 0.160 |
Why?
|
| Lymphoma, Follicular | 1 | 2019 | 420 | 0.140 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2014 | 350 | 0.120 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2012 | 29 | 0.120 |
Why?
|
| Viral Proteins | 2 | 2012 | 1959 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 936 | 0.120 |
Why?
|
| Neoplasms | 2 | 2021 | 20528 | 0.110 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2011 | 52 | 0.110 |
Why?
|
| DNA | 2 | 2022 | 7093 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 1531 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8571 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2013 | 5378 | 0.080 |
Why?
|
| Proteins | 1 | 2021 | 6070 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4893 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 6482 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2013 | 6093 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2019 | 4095 | 0.060 |
Why?
|
| Protein Binding | 2 | 2013 | 9558 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1594 | 0.060 |
Why?
|
| Jurkat Cells | 2 | 2014 | 777 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 8896 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2012 | 1688 | 0.050 |
Why?
|
| Liver | 2 | 2014 | 7594 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 14161 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 22663 | 0.050 |
Why?
|
| Peptides | 1 | 2012 | 4384 | 0.050 |
Why?
|
| Lymphoma | 1 | 2009 | 1881 | 0.050 |
Why?
|
| Mutation | 3 | 2021 | 29290 | 0.050 |
Why?
|
| Phthalazines | 1 | 2022 | 357 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 18591 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10615 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 12540 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16735 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13212 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2009 | 3424 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2014 | 23729 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 1281 | 0.040 |
Why?
|
| Humans | 10 | 2022 | 715818 | 0.040 |
Why?
|
| Phospholipid Ethers | 1 | 2014 | 10 | 0.030 |
Why?
|
| DNA Replication | 1 | 2022 | 1421 | 0.030 |
Why?
|
| Transfection | 2 | 2014 | 6089 | 0.030 |
Why?
|
| Kidney | 1 | 2009 | 6882 | 0.030 |
Why?
|
| Mice | 4 | 2013 | 80373 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2012 | 207 | 0.030 |
Why?
|
| DNA Damage | 1 | 2022 | 2434 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4266 | 0.030 |
Why?
|
| Piperazines | 1 | 2022 | 2524 | 0.030 |
Why?
|
| U937 Cells | 1 | 2011 | 275 | 0.030 |
Why?
|
| Herpesvirus 8, Human | 1 | 2012 | 240 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2011 | 369 | 0.030 |
Why?
|
| Animals | 5 | 2014 | 169404 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 619 | 0.020 |
Why?
|
| Base Sequence | 1 | 2021 | 13179 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2021 | 4277 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2014 | 2217 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 663 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 2787 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2985 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3964 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 3066 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 2459 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 11201 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2009 | 2824 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9849 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19905 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11689 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 51317 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9809 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13626 | 0.010 |
Why?
|
| Female | 2 | 2019 | 377229 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 214666 | 0.000 |
Why?
|
| Male | 1 | 2019 | 350352 | 0.000 |
Why?
|